Mark W. Sawicki, Chief Scientific Officer at Cryoport, Inc. (CYRX), sold 160,292 shares at $58.37 ($9.4M) on 2021-08-11, disclosed to the SEC on 2021-08-13.
Open-market sale of $9.4M CYRX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.37 | 74,453 | $4.3M | 46.4% |
| 2 | $58.37 | 74,453 | $4.3M | 46.4% |
| 3 | $59.11 | 3,172 | $187K | 2.0% |
| 4 | $59.11 | 3,172 | $187K | 2.0% |
| 5 | $59.83 | 2,521 | $151K | 1.6% |
| 6 | $59.83 | 2,521 |
| $151K |
| 1.6% |
| Total | $58.45 avg | 160,292 | $9.4M | 100% |
| Filing → |
| CYRX | SELL | 2025-03-26 | $9K | — | Filing → |
| CYRX | SELL | 2025-03-18 | $13K | — | Filing → |
| CYRX | SELL | 2025-03-11 | $8K | — | Filing → |